1[1]Fu JY, Masferrer JL, Seibert K, et al. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem, 1990, 86(4):1375～1379.
2[2]Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol, 1997, 24(Suppl 49):15～19.
3[3]Leslie J, Crofford, Peter E, et al. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum, 2000, 43(1):4～13.
4[4]Vane JR, Bakhle YS, Botting RM, et al. Cyclooxygenases 1 and 2. Annu Rew Pharmacol Toxicol, 1998, 38(1):97～100.
5[5]Cohn SM, Schloemann S, Tonner T, et al. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest, 1997, 99(6):1367～1379.
6[6]Smith CJ, Zhang Y, Koboldt CM, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation, Proc Natl Acad Sci USA, 1998, 95(22):13313～13318.
7[7]Schmassmann A, Peskar BM, Stettler C, et al. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol, 1998, 123(5):795～804.
8[8]Harris RC, McKanna JA, Akai Y, et al. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest, 1994, 94(6):2504～2510.
9[9]Harris RC, Cheng H, Wang J, et al. Interactions of the renin-angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase-2 in the macula densa. Acta Physiol Scand, 2000, 168(1):47～51.
10[10]Catella-Lawson F, McAdam B, Morrison BW, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther, 1999, 289(2):735～741.
